Xiangsheng Liu

机构：Zhejiang Cancer Hospital, Hangzhou Cancer Hospital · ORCID：0000-0002-5719-2838

发表论文 147 篇 · 总被引 8744 次 · h-index 54

代表论文

• LRPPRC confers enhanced oxidative phosphorylation metabolism in triple-negative breast cancer and represents a therapeutic target (2025 · Journal of Translational Medicine · 被引 19)
• Unlocking tumor barrier: annexin A2-mediated transcytosis boosts drug delivery in pancreatic and breast tumors (2025 · Nature Communications · 被引 18)
• An aptamer-drug conjugate for promising cancer therapy with comprehensive evaluation from rodents to non-human primates (2025 · Signal Transduction and Targeted Therapy · 被引 12)
• Transferrin Receptor-Targeted Aptamer–Drug Conjugate Overcomes Blood–Brain Barrier for Potent Glioblastoma Therapy (2025 · Bioconjugate Chemistry · 被引 12)
• Sortilin‐Mediated Rapid, Precise and Sustained Degradation of Membrane Proteins via mRNA‐Encoded Lysosome‐Targeting Chimera (2025 · Advanced Science · 被引 12)
• Lipid nanoparticles: A delicate nucleic acid delivery system to be further explored (2024 · Nano Today · 被引 12)